BioNeutral Laboratories Announces the Appointment of Stephen Browand As a Director to Head Military, Homeland Security and Governmental Affairs
Posted on: Wednesday, 25 June 2008, 15:02 CDT
BioNeutral announced today that Steve Browand will direct the company's efforts to sell its advanced chemical technology products to the military, Homeland Security and governmental departments. Steve Browand said, "I have reviewed the test results announced by Dr. Tierno, regarding anthrax, the attached video interview with Dr. Kielbania and Dr. Tierno and the performance of the company's formulations in combating chemical and biologic threats and I believe it to be world class. I will be meeting with military and government officials who have conveyed their interest in this powerful next generation defensive tool."
"Mr. Browand's extensive security & diverse business experience spans over 30 years from multiple sectors, including military, municipal & private. He started his career as an intelligence officer serving in the European theatre, where he gained experience in the areas of vulnerability analysis, counter terrorism, strike contingency planning, emergency management & the deployment of counter intelligence safeguards. This experience has enabled Mr. Browand to add considerable value to our company," said Raj Pamani, Director of BioNeutral.
About BioNeutral Laboratories Corporation
BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. These widely used compounds are combined in unique ways to create enhanced results.
BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. The products include BioNeutralizers and ChemoNeutralizers. BioNeutralizers disinfect, decontaminate and sterilize. BioNeutral believes it has the broadest-based, fastest acting, most effective and safest antimicrobial known. This class of products has important applications for consumers, healthcare and the military. ChemoNeutralizers irreversible bind chemical contaminant and toxin molecules and render them harmless. Product applications include industrial pollution and protection against chemical weapons of mass destruction.
About Dr. Philip Tierno
Dr. Tierno is a consultant to BioNeutral. He is the Director of Clinical Microbiology and Diagnostic Immunology at Tisch Hospital, New York University Medical Center. He is also an Associate Professor at the New York University School of Medicine, NYU College of Dentistry and SUNY School of Optometry in New York City. Dr. Tierno is a member of the NYC Mayor's MRC (Medical Reserve Corps) and a former member of New York City's task force on bioterrorism. Dr. Tierno's work in the field of microbiology has resulted in numerous articles and texts that have been published in medical and scientific journals. He is co-editor and author of several books on microbes and biological protection.
Embedded Video Available: http://www2.marketwire.com/mw/release_html_b1?release_id=410552
Contact: Email Contact Stephen J. Browand Director Governmental Affairs Email Contact Dr. Philip Tierno Consultant Email Contact
SOURCE: BioNeutral Group
Source: MARKET WIRE
Related Articles
- Reportlinker Adds Gas-to-Liquids Processes for Chemicals and Energy Production Report
- Family Care Awarded First Multiple Product Discount Medical Plan License in California
- Finisar Introduces 850nm Pigtailed Components for Military and Aerospace Applications
- iN Control Security Inc. Announces Appointment of Director of Product Applications
- NutraCea-Sponsored Study Demonstrates Benefits of Replacing Wheat Flour With Stabilized Rice Bran (SRB) in Battered and Fried Product Applications
- Research and Markets : Oil Refining Catalysts Market: Companies, Products, Applications, Catalyst Supports and U.S. Outlook
- Molecular Diagnostics 2007: Technologies, Companies, Products, Applications and WW Outlook
- AMI-Partners Study Shows Small Businesses Are Still Largely Unaware of Web-Based Personal Productivity Applications
- Read an In-Depth Profile for 657 Companies in the Worldwide Fiber Optic Products & Applications Market
- U.S. PIRG Response to American Chemistry Council's Comments on Toxic Chemicals in Baby Products
 |
 |
User Comments (0)
RSS Feeds